| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |